The forecasted sales of musculo-skeletal system medicines in Austria show a steady upward trend from 2024 to 2028. In 2024, the sales per capita are projected at 17.6 USD, which gradually increases to 18.1 USD by 2028. This indicates a consistent year-on-year growth with percentages as follows: 2024-2025 (0.6%), 2025-2026 (1.1%), 2026-2027 (0.6%), and 2027-2028 (0.6%).
When compared to the value in 2023, sales per capita have demonstrated positive growth. The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is approximately 0.57%, indicating a modest yet stable increase annually.
Future trends to watch for include potential shifts in regulatory policies, advancements in treatment technologies, and demographic changes such as an aging population, which could amplify the demand for musculo-skeletal system medicines. Additionally, market dynamics such as pricing strategies and increased competition may further influence sales trends in the coming years.
